Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 588.00
Bid: 582.00
Ask: 588.00
Change: 24.00 (4.26%)
Spread: 6.00 (1.031%)
Open: 562.00
High: 588.00
Low: 560.00
Prev. Close: 564.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 Jan 2009 16:04

RNS Number : 4846M
Gooch & Housego PLC
29 January 2009
 



For immediate release 

29 January 2009

Gooch & Housego PLC

(The "Company")

Trading Update

Gooch & Housego PLC, the specialist manufacturer of optical components and systems, today announces that it has experienced a sudden and significant drop in demand for certain of its products with the result that earnings for the year to 30 September 2009 are likely to be materially lower than the Board's original expectations for the current financial year. 

The most significant impact has been felt in the Company's key Acousto-Optics & Electro-Optics business unit where demand for acousto-optic Q-switches for general industrial, semiconductor and microelectronic applications has decreased by between a quarter and a half depending on the end user market. Whilst the order book remains strong, customers are significantly reducing their monthly requirements as they experience a similar reduction in demand for their laser systems. The effect is being felt on a global basis with the US, European and Asia-Pacific markets all affected. Indications are that demand will remain depressed for the foreseeable future.

Other sectors of the business, particularly those serving the aerospace, defence and life sciences markets have been less affected. The Company's Precision Optics, Fibre Optics and Instrumentation & Life Sciences business units are all trading broadly in line with the Board's original expectations for the current financial year.

In view of the decrease in sales steps are being taken to realign the cost base of the Company with the greatest savings taking place in the Acousto-Optics & Electro-Optics business unit.

The Company has been impacted by the recent rapid decline in the value of Sterling against the US Dollar and to a lesser extent the Euro. More than 85% of Company revenues are denominated in currencies other than Sterling with the US Dollar accounting for approximately 79% and the Euro approximately 6% with proportionately higher level of Company profits associated with the US Dollar.

The effect of the decline in the value of Sterling particularly against the US Dollar will to some extent offset the anticipated decrease in revenues at the Company's key Acousto-Optics & Electro-Optics business unit.

However, the Company's borrowings are predominantly denominated in US Dollars with approximately 85% of total borrowings in US Dollars and the balance in SterlingWhilst the US Dollar borrowings provide a natural hedge given the Company's significant US Dollar asset base and the high proportion of US Dollar revenues and profits, the fall in the value of Sterling against the US Dollar has the effect of increasing the magnitude of the Company's debt when translated into Sterling

Consequently, the Company is in discussions with its bankersThe Royal Bank of Scotland plcconcerning the impact of these currency issues that affect, and may continue to affect, certain bank covenant calculations. 

The Board is confident that the Company will meet its bank interest and debt repayment obligations to its bankers as they fall due. 

The Company believes that it is not appropriate to finalise its accounts for the year ended 30 September 2008 until the discussions with its bankers have been satisfactorily completed. Following completion of these discussions, the date of the Company's Annual General Meeting will be announced.

For further information, please contact:

Gareth Jones, Chief Executive Officer, 01460 256440

Peter J. Quinn, Chief Financial Officer, 01460 256446

Tim Thompson/Chris McMahon, Buchanan Communications Ltd, 020 7466 5000

Patrick Robb, Investec Bank (UK) Ltd, 020 7597 5169

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEDFMUSUSESF
Date   Source Headline
19th Sep 20083:11 pmRNSShare Option Purchase
4th Jul 20087:00 amRNSAcquisition of General Optics
24th Jun 20087:00 amRNSChange of NOMAD & Broker
17th Jun 20087:00 amRNSInterim Results
27th May 20087:00 amRNSIFRS
13th May 20086:00 amRNSNotice of Results
9th Apr 20087:00 amRNSTrading Update
28th Mar 20089:59 amRNSAnnual Report and Accounts
12th Mar 20084:37 pmRNSAdditional Listing
13th Feb 200811:00 amRNSAGM Statement
5th Feb 20087:01 amRNSVendor Appreciation Award
22nd Jan 20087:01 amRNSGlobal Integration
7th Jan 20088:53 amRNSAdditional Listing
7th Jan 20087:01 amRNSSIFAM Order
4th Jan 200812:32 pmRNSDirector Shareholding
21st Dec 20074:46 pmRNSHolding(s) in Company
21st Dec 20074:35 pmRNSAdditional Listing
7th Dec 20073:00 pmRNSLong Term Incentive Plan
3rd Dec 200712:20 pmRNSAdditional Listing
30th Nov 20073:44 pmRNSHolding(s) in Company
27th Nov 20077:00 amRNSAppointment
27th Nov 20077:00 amRNSPreliminary Results
15th Nov 20077:01 amRNSAppointment
29th Oct 20077:01 amRNSNotice of Results
4th Oct 20077:01 amRNSFull Year Trading Update
23rd Aug 20078:26 amRNSAdditional Listing
22nd Aug 20075:38 pmRNSDirector Shareholdings
17th Aug 20076:23 pmRNSAIM Rule 26
16th Aug 20072:12 pmRNSAdditional Listing
14th Aug 200712:36 pmRNSLTIP Awards
10th Aug 20075:18 pmRNSDirector Shareholdings
17th Jul 20074:16 pmRNSDirector of Sales Appointment
5th Jun 20077:02 amRNSInterim Results
31st May 20079:55 amRNSTotal Voting Rights
10th May 20079:58 amRNSHolding(s) in Company
9th May 20077:01 amRNSNotice of Results
8th May 20071:53 pmRNSAdditional Listing
8th May 20077:02 amRNSAcquisition
11th Apr 20077:01 amRNSTrading Update
8th Mar 20075:54 pmRNSHolding(s) in Company
14th Feb 20077:01 amRNSAGM Statement
8th Feb 20073:41 pmRNSHolding(s) in Company
1st Feb 200712:43 pmRNSTotal Voting Rights
1st Feb 200712:42 pmRNSHolding(s) in Company
9th Jan 200710:26 amRNSAdditional Listing
20th Dec 200611:54 amRNSTotal Voting Rights
30th Nov 200610:07 amRNSNotice of Dividend
29th Nov 200611:18 amRNSPreliminary Results-Amendment
29th Nov 20067:02 amRNSAppointment of Director
29th Nov 20067:02 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.